Study Testing a New Medication to Slow Parkinson’s Progression is Now Recruiting around The United States


A compound that researchers believe may lower the risk of Parkinson’s disease (PD) and slow progression is now in the final stage of clinical testing. The study was funded by the Michael J Fox Foundation for Parkinson’s Research.

Read more about this new advance here: